Jump to the top of the page

Team Ward

San Francisco skyline
  • Laura Ward

    Laura Harrison Ward

    Managing Director, Wealth Advisor

    +1 415 248 5906
    View profile
  • Lisa Kwong

    Lisa Kwong

    Senior Client Relationship Associate

    +1 415 796 6867
    View profile

About William Blair

William Blair is a premier global boutique with expertise in investment banking, investment management, and private wealth management. We provide advisory services, strategies, and solutions to meet our clients’ evolving needs. As an independent and employee-owned firm, together with our strategic partners, we operate in more than 20 offices worldwide.*

  • 1935

    Year William Blair was founded

  • 1,900+

    Employees worldwide

  • 147 billion+

    Client assets

  • 90 Years

    Independent and employee-owned

  • 20+

    Offices worldwide

  • ~650

    Companies under coverage

As of December 31, 2024
*Includes strategic partnerships with Allier Capital, BDA Partners, and Poalim Capital Markets.

More about William Blair affiliated entities

Thought Leadership

  • The 2025 Tax Reference Guide

    William Blair's tax reference guide for income earned in 2025 and tax returns filed in 2026 is now available.

    Read more
  • Woman at a computer

    Risk: Understanding and Managing an Inevitable Part of Investing

    Identifying the various types of risk that investors face can help you think strategically about how to manage risk in a way that aligns with your goals and objectives.

    Read more
  • Financing a College Education: Options to Consider

    Tips for developing the best strategy while keeping your financial goals intact.

    Read more

Our Latest News

  • William Blair Initiates Coverage of Seven Companies in the Obesity Treatment Space

    William Blair initiated research coverage of Altimmune, Inc. (ALT $5.91), BioAge Labs, Inc. (BIOA $4.18), Corbus Pharmaceuticals Holdings, Inc. (CRBP $7.50), Skye Bioscience, Inc. (SKYE $2.89), Structure Therapeutics, Inc. (GPCR $21.09), Terns Pharmaceuticals, Inc. (TERN $3.71), and Zealand Pharma A/S (ZEAL-CSE DKK 719.00).

    Read more
  • Mapal OS Has Completed a Dividend Recapitalization

    William Blair acted as exclusive financial advisor to Mapal OS, a portfolio company of PSG Equity, in connection with its dividend recapitalization.

    Read more
  • Naviant Has Received a Strategic Investment from DNS Capital

    William Blair acted as the exclusive financial advisor to Naviant in connection with its strategic investment from DNS Capital.

    Read more

Ready to start a conversation? Contact us today.

This content is for informational and educational purposes only and not intended as investment advice or a recommendation to buy or sell any security. Investment advice and recommendations can be provided only after careful consideration of an investor's objectives, guidelines, and restrictions.

Copyright © 2025 William Blair & Company, L.L.C. | Privacy Terms

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures